Physician profile
Christopher W Lee
NPI 1386081610
$268.70
in general payments reported to CMS, 2019-2025
9 companies · $31.28 in 2025
The $31.28 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $35.40 · 2021: $15.59 · 2022: $107 · 2023: $54.25 · 2024: $24.72 · 2025: $31.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $110.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $95.75 | 2022 | |
| Glaxosmithkline, LLC. | $35.40 | 2020 | |
| Amgen INC. | $31.12 | 2023 | Evenity, Prolia |
| Abbott Laboratories | $24.72 | 2024 | Freestyle Libre 3 |
| Davol INC. | $23.13 | 2023 | Phasix Mesh |
| Pfizer INC. | $15.91 | 2025 | |
| Ge Healthcare | $15.59 | 2021 | |
| Merck Sharp & Dohme LLC | $15.37 | 2025 | Capvaxive, Gardasil 9 |
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.